Bifeprunox | B2921

Bifeprunox shows positive effects in treating psychotic symptoms in schizophrenia. It is a third-generation antipsychotic agent which acts as a partial agonist at dopamine D2 receptors and is an efficacious agonist at serotonin 5-HT1A receptors. It shows little interaction at 5HT(2A/2C), muscarinic or histaminergic H1 receptors.

Bifeprunox shows positive effects in treating psychotic symptoms in schizophrenia. It is a third-generation antipsychotic agent which acts as a partial agonist at dopamine D2 receptors and is an efficacious agonist at serotonin 5-HT1A receptors. It shows little interaction at 5HT(2A/2C), muscarinic or histaminergic H1 receptors.

B2921 | Bifeprunox DataSheet

Alternate Name/Synonyms: Bifeprunoxum; 7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3H-1,3-benzoxazol-2-one; 7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3h)-benzoxazolone

Appearance: Solid

Formulation:

CAS Number: 350992-10-8

Structure Available?: True

Peptide sequence:

Salt Form: false

Molecular Formula: C₂₄H₂₃N₃O₂

Molecular Weight: 385.46

Cell-Permeable?: True

Purity: 97%

Solubilities: Soluble in DMSO in 0

Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.

Country of Origin: USA

Tag Line: A partial agonist of D2 receptor and efficacious agonist of 5-HT1A receptor

MDL Number:

PubChem CID: 208951

SMILES: C1CN(CCN1CC2=CC(=CC=C2)C3=CC=CC=C3)C4=CC=CC5=C4OC(=O)N5

InChi: InChI=1S/C24H23N3O2/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19/h1-11,16H,12-15,17H2,(H,25,28)

InChi Key: CYGODHVAJQTCBG-UHFFFAOYSA-N